FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide remains in shortage; compounding is still permitted.
What changed & why it matters
Med Spa Radar recorded an FDA drug-shortage update at the federal level, dated June 11, 2026, in the GLP-1 Compounding category, naming Liraglutide.
The FDA drug-shortage list is the primary switch for whether Liraglutide may be compounded: shortage status has been the main legal basis for compounded semaglutide and tirzepatide, so a change to it narrows or widens what a 503A/503B pharmacy may prepare — often on a short timeline.
- Type
- FDA Drug Shortages
- Jurisdiction
- Federal
- Category
- GLP-1 Compounding
- Substance
- Liraglutide
- Recorded
- June 11, 2026
What this means for your specific practice — the exact step to take, the deadline to calendar, or the supplier detail to check — is in the member "what to do" below. This page is the free record of what changed and why it matters.
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
FDA Drug Shortages · primary source ↗
Related alerts
- FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
- FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
- FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
- FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
- FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
- FDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Monitoring, not legal advice.